Dabrafenib
Dabrafenib Brand Name– Tafinlar What is Dabrafenib Dabrafenib is a kinase inhibitor that inhibits cell growth in BRAF V600 mutation-positive tumors. Using an FDA-approved test, confirm the presence of the BRAF V600 mutation in tumor specimens prior to initiation of treatment. Dabrafenib is indicated as single-agent therapy for the treatment of unresectable or metastatic melanoma …
